|
Title
|
Drug safety: COVID-19 complicates already challenged FDA foreign inspection program : testimony before the Committee on Finance, U.S. Senate /
|
|
Format
|
online resource
|
|
Internet Access
|
https://purl.fdlp.gov/GPO/gpo139201
|
|
Author
|
United States. Government Accountability Office, author.
|
|
Published
|
[Washington, D.C.] : United States Government Accountability Office, 2020.
|
|
|
|
|
SuDoc Number
|
GA 1.5/2:GAO-20-626 T
|
|
Item Number
|
0546-D-01 (online)
|
|
Description
|
1 online resource (26 pages) : color illustrations, color maps.
|
|
Content Type
|
text
|
|
Series
|
(Testimony ; GAO-2-626T.)
|
|
General Note
|
"For release on delivery, expected at 2:30 p.m. ET, Tuesday, June 2, 2020."
|
|
Bibliography
|
Includes bibliographical references.
|
|
Metadata Source
|
Description based on online resource, PDF version; title from cover (GAO, viewed Jun. 4, 2020).
|
|
Subject
|
United States. Food and Drug Administration -- Rules and practice.
|
|
Subject - LC
|
COVID-19 (Disease) -- Treatment -- United States.
|
|
|
Drugs -- Inspection -- United States.
|
|
|
Drugs -- United States -- Safety measures -- Evaluation.
|
|
|
Pharmaceutical industry -- Quality control -- Evaluation.
|
|
|
Drugs -- Safety regulations -- United States -- Evaluation.
|
|
|
Drug reimportation -- United States -- Evaluation.
|
|
|
Imports -- United States -- Safety measures -- Evaluation.
|
|
Added Entry
|
Denigan-Macauley, Mary, author.
|
|
Added Entry
|
United States. Congress. Senate. Committee on Finance, sponsoring body.
|
|
URL
|
Address at time of PURL creation https://www.gao.gov/assets/710/707345.pdf
|
|
|
|
|
Holdings
|
All items
|
|
|
|
|
OCLC Number
|
(OCoLC)1156966114
|
|
CGP Record Link
|
https://catalog.gpo.gov:443/F/?func=direct&doc_number=001122850&local_base=GPO01PUB
|
|
System Number
|
001122850
|